Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1225297
PUBLISHER: IMARC | PRODUCT CODE: 1225297
Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global influenza diagnostics market size reached US$ 893.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,461.7 Million by 2028, exhibiting a growth rate (CAGR) of 6.55% during 2023-2028.
Influenza, or flu, refers to a viral infection that mainly affects the human respiratory system, including the nose, throat, and lungs. Influenza diagnostics includes numerous immunoassay tests that aid in detecting the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. Some of the commonly available diagnostic tests include rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. Healthcare facilities can assess the precision of these tests by looking at their sensitivity and specificity, which are crucial factors that determine their accuracy levels.
Influenza Diagnostics Market Trends:
- The elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market. Moreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor. Furthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, test type, type of flu and end user.
Breakup by Product:
- Test Kit and Reagents
- Instruments
- Others
Breakup by Test Type:
- Molecular Diagnostic Tests
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Tests
- Other Molecular Tests
- Traditional Diagnostic Tests
- Rapid Influenza Diagnostic Tests
- Viral Culture Tests
- Direct Fluorescent Antibody Test
- Serological Tests
Breakup by Type of Flu:
- Type A Flu
- Type B Flu
- Type C Flu
Breakup by End User:
- Hospitals
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Coris Bioconcept, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd (Roche Holding AG), Hologic Inc., Meridian Bioscience Inc., Qiagen N.V, Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.) and Siemens Healthineers AG (Siemens AG).
- Key Questions Answered in This Report
- 1. What was the size of the global influenza diagnostics market in 2022?
- 2. What is the expected growth rate of the global influenza diagnostics market during 2023-2028?
- 3. What are the key factors driving the global influenza diagnostics market?
- 4. What has been the impact of COVID-19 on the global influenza diagnostics market?
- 5. What is the breakup of the global influenza diagnostics market based on the product?
- 6. What is the breakup of the global influenza diagnostics market based on the test type?
- 7. What is the breakup of the global influenza diagnostics market based on type of flu?
- 8. What is the breakup of the global influenza diagnostics market based on the end user?
- 9. What are the key regions in the global influenza diagnostics market?
- 10. Who are the key players/companies in the global influenza diagnostics market?
Product Code: SR1423A138_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Influenza Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Test Kit and Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Test Type
- 7.1 Molecular Diagnostic Tests
- 7.1.1 Market Trends
- 7.1.2 Key Segments
- 7.1.2.1 Polymerase Chain Reaction
- 7.1.2.2 Isothermal Nucleic Acid Amplification Tests
- 7.1.2.3 Other Molecular Tests
- 7.1.3 Market Forecast
- 7.2 Traditional Diagnostic Tests
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Rapid Influenza Diagnostic Tests
- 7.2.2.2 Viral Culture Tests
- 7.2.2.3 Direct Fluorescent Antibody Test
- 7.2.2.4 Serological Tests
- 7.2.3 Market Forecast
8 Market Breakup by Type of Flu
- 8.1 Type A Flu
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Type B Flu
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Type C Flu
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Diagnostic Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Becton Dickinson and Company
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Coris Bioconcept
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Danaher Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 DiaSorin S.p.A.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 SWOT Analysis
- 15.3.7 Hologic Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Meridian Bioscience Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Qiagen N.V
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Quidel Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.12 Siemens Healthineers AG (Siemens AG)
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 Abbott Laboratories
Product Code: SR1423A138_Report
List of Figures
- Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million US$), 2017-2022
- Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2022
- Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2022
- Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2022
- Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2022
- Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2022
- Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2022
- Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
- Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
- Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
- Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million US$), 2023-2028
- Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Influenza Diagnostics Market: Competitive Structure
- Table 8: Global: Influenza Diagnostics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.